Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 105,654 | 103,056 | 101,728 | 103,386 | 93,688 |
| Cost of Goods | 1,386 | 1,480 | 1,339 | 1,316 | 1,250 |
| Gross Profit | 104,268 | 101,576 | 100,389 | 102,070 | 92,438 |
| Operating Expenses | 89,801 | 79,557 | 68,794 | 70,954 | 65,919 |
| Operating Income | 14,853 | 22,499 | 31,934 | 31,432 | 26,769 |
| Other Income | 3,581 | 1,777 | 1,070 | 630 | 80 |
| Pre-tax Income | 18,434 | 24,276 | 33,004 | 32,062 | 26,849 |
| Income Tax | 2,555 | 7,675 | -1,604 | 4,650 | 4,052 |
| Net Income Continuous | 15,879 | 16,601 | 34,608 | 27,412 | 22,797 |
| Net Income | $15,879 | $16,601 | $34,608 | $27,412 | $22,797 |
| EPS Basic Total Ops | 0.15 | 0.15 | 0.32 | 0.26 | 0.22 |
| EPS Basic Continuous Ops | 0.15 | 0.15 | 0.32 | 0.26 | 0.22 |
| EPS Diluted Total Ops | 0.14 | 0.13 | 0.30 | 0.24 | 0.20 |
| EPS Diluted Continuous Ops | 0.14 | 0.14 | 0.30 | 0.24 | 0.20 |
| EBITDA(a) | $14,209 | $25,106 | $30,816 | $32,864 | $28,677 |